Hematology & Oncology Billing & Coding Guide
Chemotherapy administration 96401-96549, J-code drugs, prolonged infusion units, JW waste.
Common Hematology & Oncology CPT Codes
Ranked by claim frequency, with current MPFS work RVUs and global periods.
| Code | Description | Work RVU | Total RVU | Global |
|---|---|---|---|---|
| 96401 | Chemo anti-neopl sq/im | 0.21 | 2.15 | XXX |
| 96402 | Chemo hormon antineopl sq/im | 0.19 | 1.16 | XXX |
| 96409 | Chemo iv push sngl drug | 0.24 | 3.13 | XXX |
| 96411 | Chemo iv push addl drug | 0.20 | 1.71 | ZZZ |
| 96413 | Chemo iv infusion 1 hr | 0.28 | 3.99 | XXX |
| 96415 | Chemo iv infusion addl hr | 0.19 | 0.85 | ZZZ |
| 96416 | Chemo prolong infuse w/pump | 0.21 | 3.99 | XXX |
| 96417 | Chemo iv infus each addl seq | 0.21 | 1.99 | ZZZ |
| 96522 | Refill/maint pump/resvr syst | 0.21 | 3.75 | XXX |
| 96521 | Refill/maint portable pump | 0.21 | 4.30 | XXX |
| 96523 | Irrig drug delivery device | 0.04 | 0.78 | XXX |
| 38221 | Dx bone marrow biopsies | 1.25 | 5.00 | XXX |
| 38222 | Dx bone marrow bx & aspir | 1.40 | 5.30 | XXX |
| 85025 | Complete cbc w/auto diff wbc | 0.00 | 0.00 | XXX |
| 85027 | Complete cbc automated | 0.00 | 0.00 | XXX |
| 77373 | Strtctc bdy rad ther tx dlvr | 0.00 | 29.30 | XXX |
| 77387 | Guidance for radj tx dlvr | 0.68 | 1.09 | XXX |
| 99213 | Office o/p est low 20 min | 1.30 | 2.85 | XXX |
| 99214 | Office o/p est mod 30 min | 1.92 | 4.06 | XXX |
| 99215 | Office o/p est hi 40 min | 2.80 | 5.76 | XXX |
What Hematology & Oncology practices are leaving on the table
High-value services that consistently get under-billed across the specialty. Each one is rooted in current 2026 fee schedule and policy updates.
Modifier 25 underbilling on chemotherapy days: Many practices administer chemo without billing concurrent E/M even when significant visit occurs. Example: Patient on 96413 infusion; physician spends 25 minutes reviewing new labs, adjusting supportive care plan, counseling on toxicity. This justifies 99214 (1.92 RVU = ~$85-95 commercial reimbursement). Impact: 40 chemo visits/month × 2-3 missed E/M codes = $6,800-10,200 annually. Workflow: Create chemo visit template with separate 'visit assessment' section (distinct from admin); train RNs to flag clinician if visit-level work occurs.
Bone marrow biopsy bilateral or sequential: Missed 38222 base code and modifier 50 or 58 opportunity. Example: Suspected leukemia workup often includes bilateral iliac crest biopsies or follow-up biopsy post-induction therapy. Many practices bill only one 38221, missing $200-300 per additional site/procedure. Impact: 5-8 bilateral/sequential biopsies/month = $1,200-2,400 monthly ($14,400-28,800 annually). Workflow: Pathology/procedure note must explicitly state 'bilateral' or 'left iliac and right iliac' or 'repeat biopsy day 14'; code 38222 per site with modifier 50 (bilateral) or 58 (staged).
Infusion duration documentation for add-on hours: Practices often fail to document actual infusion minutes, resulting in conservative 96413-only billing (missing 96415 add-on codes). Example: Three-hour docetaxel infusion documented as '96413' when it should be '96413, 96415, 96415' (0.28 + 0.19 + 0.19 RVU = ~$16-20 per additional hour). Impact: 20 multi-hour infusions/month × 2 missed hours × $18 = $7,200 annually. Workflow: Require RN to document infusion start time and end time in minutes on the encounter form or EHR template; pre-populate add-on codes in billing system based on duration input.
Radiation guidance add-on (77387) underreported: Many practices deliver 77373 (structured body RT) without separately documenting or billing 77387 (guidance). Modern linacs provide real-time guidance (image-guided radiation therapy, IGRT). Example: Patient treated 25 fractions with daily IGRT; billing 77373 only = 0 RVUs for guidance. Billing 77387 each fraction = 0.68 RVU × 25 = $425-500. Workflow: Radiation oncology physicist must document in daily treatment record whether imaging guidance was used (e.g., 'cone-beam CT performed pre-treatment') for each fraction; append modifier 76 (repeat procedure) per fraction if daily guidance; cycle claims through oncology billing specialist review before submission to ensure 77387 consistency.
Code pairs that auto-bundle to CO-97
From the National Correct Coding Initiative for Hematology & Oncology. The rationale tells you when a modifier legitimately bypasses the edit and when it cannot.
CBC with auto diff (85025) and automated CBC (85027) bundle on the same day for the same patient. Bill only one code per encounter unless separate specimens or clinical indication documented (e.g., morning vs. post-transfusion). No modifier 59 bypass without clear medical necessity in the record.
IV push single drug (96409) is base code; additional drugs on same infusion session use 96411 (add-on, global ZZZ). Never bill 96409 twice on same day for multiple drugs. If distinct infusions at different times, append modifier 59 with documented interval and clinical reason.
IV infusion first hour (96413) bundles with additional hours (96415, global ZZZ). Bill 96413 once, then 96415 for each additional hour. Billing 96413 multiple times for the same patient on same day triggers RAC denials. Document actual infusion duration in minutes in the record.
Bone marrow biopsy only (38221) and biopsy with aspiration (38222) are mutually exclusive on same anatomic site same day. Use 38222 if both procedures performed. If bilateral or separate sessions on different dates, modifier 50 or 58 with documentation of clinical reason and timing.
Modifier Guidance for Hematology & Oncology
When each modifier legitimately applies in this specialty, with denial-pattern context and audit-defense documentation.
Modifier 25 appends to E/M code (e.g., 99214-25) when a significant, separately identifiable office visit occurs on same day as a procedure. Example: Patient presents for chemotherapy infusion (96413) and separately, physician performs complex history, exam, and medical decision-making for new neuropathy symptoms, resulting in plan modification. Chemotherapy alone does not constitute a separately billable E/M. Chart must show distinct E/M service with its own assessment and plan unrelated to chemo administration.
Modifier 59 (distinct procedural service) applies when normally bundled codes are performed as separate, distinct services. Example: 96409 (IV push single drug, docetaxel) and 96413 (IV infusion single drug, pemetrexed) same day, distinct chemotherapy regimen. Document time interval between services, separate drug preparation, and separate clinical indication. RAC scrutinizes 59 abuse; maintain detailed infusion logs with clock times and drug names to defend.
Modifier GP applies to codes delivered under outpatient physical therapy plan of care. None of the Hematology & Oncology CPTs in this dataset use GP (chemo, radiation, bone marrow biopsy, and E/M are not PT services). If practice refers to PT for lymphedema post-cancer surgery and bills E/M or ancillary codes, do not append GP unless PT supervised the specific service.
Modifier 57 appends to the E/M service (e.g., 99215-57) that resulted in the initial decision to perform a major procedure. Example: Office visit where oncologist first decides patient needs bone marrow biopsy (38222) for suspected leukemia. Only one 57 modifier per episode of care per procedure. Not used for chemotherapy or radiation therapy initiation (those are not global period surgeries).
Modifier 58 applies to staged or related procedures by same physician during postoperative period of a prior procedure. Example: Bone marrow biopsy (38222) on day 1, followed by repeat biopsy (38222-58) on day 5 to assess treatment response. Requires documentation of the planned, staged nature of the procedure or clear clinical indication for the related return. Helps bypass post-operative visit bundles.
Documentation requirements
What needs to live in the encounter note for these codes to survive a payer audit.
- Date, time, and duration of chemotherapy infusion (in minutes) to support 96413/96415 base/add-on code selection and prevent duplicate billing for same infusion window.
- Specific drug name, dose, and route (IV push vs. infusion vs. SQ/IM) for each chemotherapy administration to justify distinct codes (96409 vs. 96413 vs. 96401) and prevent incorrect bundling.
- Baseline and post-procedure laterality and anatomic site (left hip vs. right hip) for bone marrow biopsies to support modifier 50 (bilateral) or 59 (distinct site) if multiple sites biopsied on same day.
- Separate problem list or assessment/plan entry for the E/M service when appending modifier 25 to distinguish the visit component from the procedure component, showing distinct clinical decision-making unrelated to routine chemo admin.
- Pre-service and post-service imaging/labs (e.g., CBC before and after infusion day) to support medical necessity for same-day CBC codes (85025/85027) and defend against duplicate lab denials.
- Radiation therapy delivery summary (dose, fractions, site) for structured body RT (77373) and guidance codes (77387) to establish whether guidance was actually performed or if code was incorrectly billed as a standalone service.
OIG and audit triggers in Hematology & Oncology
Patterns that show up in OIG Work Plans, RAC audits, and CERT improper payment reviews. Build internal compliance checks around these.
RAC pattern: Duplicate chemotherapy infusion billing (96413 billed multiple times for single infusion episode). Defense: Infusion log with entry/exit clock times, signature of RN, and drug lot numbers for each unique infusion event. Practices submitting one claim per patient per day with three 96413 codes for a three-hour infusion will trigger rework demand.
OIG Work Plan 2026 focus on oncology billing: Radiation therapy add-on codes (77387) billed without corresponding base code (77373) or without evidence guidance was actually delivered (e.g., no daily physics note). Defense: Detailed radiation prescription in chart showing planned guidance, physicist notes documenting actual guidance delivery, and treatment summary linking each guidance code to specific fraction date.
Bone marrow procedure coding abuse: Billing both 38221 and 38222 on same date for same site (biopsy only vs. biopsy+aspirate). CMS lists this as mutually exclusive. Defense: Single note documenting only one procedure performed, or if both performed, use 38222 only. If two separate sites or dates, document clear clinical indication and append modifier 50 or 58.
CBC bundling patterns: Practices billing 85025 and 85027 on same day claiming 'one is QC check, one is clinical result.' CMS bundles these; only one CBC per day per patient except in rare instances (e.g., pre-transfusion and post-transfusion same day). Defense: Clinical note explicitly stating separate medical indication, timing, and result interpretation for each code. Missing documentation triggers CARC 50 denials.
Payer-specific billing notes
Where the major payers diverge from generic Medicare rules in Hematology & Oncology.
ME Medicare +
CMS LCD L33822 (Chemotherapy Administration) requires baseline labs (CBC minimum) within 14 days prior to first chemo administration; billing 85025/85027 on chemo day acceptable only if prior baseline missing. CMS bundles 85025 and 85027; never bill both same day. LCD L33823 (Bone Marrow Biopsy) mandates medical necessity documentation (suspected malignancy, response assessment, etc.); prior authorization not required but chart must support indication. For radiation therapy (77373, 77387), CMS requires a signed radiation oncology treatment plan in chart before first delivery date. 2026 focus: Prior authorization implementation for new cancer diagnoses (C80.1 malignant neoplasm unspecified) to reduce unnecessary staging labs; practices must submit treatment plan with initial auth request.
UN UnitedHealthcare +
UnitedHealthcare (Optum) delegates chemotherapy and radiation oncology to contracted oncology networks in most regions; verify delegation status in credentialing file. For non-delegated regions, UHC requires prior authorization for all 96400-series chemotherapy codes (request must include drug name, dose, frequency, and treatment plan). UHC bundles 85025 and 85027 identical to Medicare. Bone marrow procedures (38221, 38222) require prior auth if diagnosis suggests non-malignant hematologic disorder (e.g., aplastic anemia, ITP). UHC allows modifier 25 on E/M with chemo on same day if E/M is separately identifiable; documentation standard is moderate (not high). Verify delegation status by region at start of each month to avoid claim routing delays.
AN Anthem +
Anthem BCBS utilizes AIM (Anthem Integrated Management) for oncology prior authorization. All new chemotherapy regimens (96409, 96413, 96416) for first-line treatment require AIM submission with: clinical summary, stage/performance status, treatment plan, and drug dosing. Anthem bundles 85025/85027 and does NOT allow modifier 59 bypass without explicit policy review. Bone marrow biopsy (38222) requires medical necessity for aplastic anemia or immune thrombocytopenia (non-malignant); if malignancy-related, authorization required only if code is flagged in regional edits. Anthem allows modifier 25 on E/M with procedure same day; requires 5-minute minimum distinct E/M (lower threshold than Medicare). Radiation therapy (77373, 77387) often requires authorization for >30 fractions; submit treatment plan upfront.
CI Cigna +
Cigna utilizes eviCore for radiation oncology and some oncology medical management reviews. Prior authorization required for all intensive chemotherapy regimens (e.g., multi-drug combinations >3 agents, inpatient high-dose chemo). Cigna's LCD equivalent for bone marrow biopsy requires documented indication in chart (malignancy, cytopenias with unclear etiology, post-transplant monitoring); prior auth NOT required. Cigna bundles 85025/85027 per Medicare standard. Modifier 25 on E/M + chemo same day allowed if note shows separate complexity or new problem addressed (standard: E/M supports new symptom or medication change). For 77373/77387 radiation codes, Cigna requires treatment planning document and weekly physicist notes during treatment. Cigna denies CARC 50 (duplicate procedure) frequently on same-day chemo codes; strong infusion time documentation critical for appeal.
Standard Hematology & Oncology coding workflow
Step 1: Review visit note and procedure logs; identify primary service type (E/M, chemo admin, procedure, lab, radiation). Step 2: For chemotherapy: extract drug name, route (push/infusion/SQ), and clock time start/stop to select correct 96400-series code and calculate infusion hours for add-on codes. Step 3: Check for same-day E/M or additional procedures; if E/M separately identifiable, append modifier 25 to E/M code only. Step 4: For lab codes (CBC), verify order date and specimen type; avoid billing 85025 and 85027 on same day without documented clinical justification. Step 5: Validate global periods and modifier appropriateness (59 only with interval/distinct reason, 50 for bilateral bone marrow same site); submit with supporting doc strip (infusion times, drug labels, imaging reports).
Get the full PayerReady toolkit
Credentialing + billing/coding tools built for Hematology & Oncology, free access with enrollment.
Start free →Run this code through our claim audit tool
Check NCCI bundling, MUE limits, and modifier logic before submission.
Try the auditor →Verified against CMS 2026 code set, current NCCI Quarterly Updates, and the X12 Claim Adjustment Reason Code reference. Last updated April 15, 2026. See data sources and methodology.
Did this page help?
Quick signal so we know what to improve.
If you want a code reference page that doesn't exist yet, email coding@payerready.com.
Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.
Reviewed by the PayerReady Medical Coding Team
Verified against the CMS 2026 code set on May 31, 2026.
Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team